Clinical Trial Update: Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the safety and efficacy of RX-10100 for Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• RX-10100

Snippet

Sponsor: Rexahn Pharmaceuticals, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED